Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CCR6 | P51684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29506422 | 0.86 | PABPC1 (0.52) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL15453251 | 0.86 | PABPC1 (0.52) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL87813 | 0.82 | PABPC1 (0.56) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL798498 | 0.80 | PABPC1 (0.40) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL28740125 | 0.80 | PABPC1 (0.55) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL28218656 | 0.80 | PABPC1 (0.55) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL27860753 | 0.79 | KMT2A (0.50) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL28124446 | 0.78 | PABPC1 (0.41) | ALDH1A1PABPC1TSHRHSD17B10TRPV1 | |
| SCHEMBL31346513 | 0.77 | ALDH1A1 (0.58) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL3972303 | 0.77 | ALDH1A1 (0.58) | ALDH1A1KDM4EGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110753881-B | Alkali-developable photosensitive resin composition, dry film, cured product, and printed wiring board | 太阳控股株式会社 | 2024-06-21 | — | — | CN | disclosed |
| WO-2023132214-A1 | CURABLE COMPOSITION AND CURED PRODUCT | 株式会社カネカ | 2023-07-13 | — | — | WO | disclosed |
| CN-113543897-B | Method for producing polarizing film | 日东电工株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-115867836-A | Polarizing film, optical film and image display device | 日东电工株式会社 | 2023-03-28 | — | — | CN | disclosed |
| CN-114930211-A | Method for producing polarizing film | 日东电工株式会社 | 2022-08-19 | — | — | CN | disclosed |
| CN-114561172-A | Adhesive composition for polarizing film, optical film, and image display device | 日东电工株式会社 | 2022-05-31 | — | — | CN | disclosed |
| CN-110651336-B | Conductive paste composition, electrode device comprising same, and method for producing conductive paste composition | 株式会社钟化 | 2022-05-17 | — | — | CN | disclosed |
| WO-2022071387-A1 | POLARIZING FILM, OPTICAL FILM, AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2022-04-07 | — | — | WO | disclosed |
| CN-110168035-B | Adhesive composition for polarizing film, optical film, and image display device | 日东电工株式会社 | 2022-03-11 | — | — | CN | disclosed |
| CN-110268291-B | Curable resin composition for polarizing film, and method for producing same | 日东电工株式会社 | 2022-03-08 | — | — | CN | disclosed |
| CN-104281005-A | Curable resin composition, cured product thereof, printed circuit board comprising the same, and method for producing the cured product | TAIYO INK MFG CO LTD | 2015-01-14 | — | — | CN | disclosed |
| US-20150010735-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, PRINTED CIRCUIT BOARD COMPRISING THE SAME, AND METHOD FOR PRODUCING THE CURED PRODUCT | TAIYO INK MFG. CO., LTD. (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20140034371-A1 | PATTERN FORMING METHOD, ALKALI-DEVELOPABLE THERMOSETTING RESIN COMPOSITION, PRINTED CIRCUIT BOARD AND MANUFACTURING METHOD THEREOF | TAIYO INK MFG. CO., LTD. (JP) | 2014-02-06 | — | — | US | disclosed |
| US-8115027-B2 | NPY Y5 antagonist | SHIONOGI & CO., LTD. (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20110039802-A1 | NPY Y5 ANTAGONIST | KAWANISHI YASUYUKI | 2011-02-17 | — | — | US | disclosed |
| US-20100292500-A1 | NPY Y5 ANTAGONIST | KAWANISHI YASUYUKI | 2010-11-18 | — | — | US | disclosed |
| US-7781461-B2 | NPY Y5 antagonist | KAWANISHI YASUYUKI | 2010-08-24 | — | — | US | disclosed |
| US-7265130-B2 | NPY Y5 antagonist | SHIONOGI & CO., LTD. (JP) | 2007-09-04 | — | — | US | disclosed |
| US-7202246-B2 | Spiro-rifamycin derivatives targeting RNA polymerase | CUMBRE PHARMACEUTICALS INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20050277633-A1 | E.g., rifamycin S derivatives such as 2',2'-Dimethyl-3,4-piperazinorifamycin S and Spiro[N-methyl-piperidine-3,4-piperazinorifamycin S; treating bacterial infections, especially those caused by rifamycin-resistant bacteria | CUMBRE INC. (US) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292500-A1 | NPY Y5 ANTAGONIST | NPY5R, NPY1R, NPY2R | ALDH1A1 4599/4885KDM4E 1627/4885GAA 3316/4885 |
| US-20050277633-A1 | E.g., rifamycin S derivatives such as 2',2'-Dimethyl-3,4-piperazinorifamycin S and Spiro[N-methyl-piperidine-3,4-piperazinorifamycin S; treating bacterial infections, especially those caused by rifamycin-resistant bacteria | RIF1, MAPRE1, MAPRE2 | ALDH1A1 1322/4885KDM4E 402/4885GAA 1432/4885 |
| US-20110039802-A1 | NPY Y5 ANTAGONIST | NPY5R, NPY1R, NPY2R | ALDH1A1 4517/4885KDM4E 1653/4885GAA 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.